nodes	percent_of_prediction	percent_of_DWPC	metapath
Antazoline—Cyclizine—SULT1E1—coronary artery disease	0.0376	0.314	CrCbGaD
Antazoline—Tolazoline—HRH2—coronary artery disease	0.0234	0.195	CrCbGaD
Antazoline—Bepridil—ATP1A1—coronary artery disease	0.0129	0.108	CrCbGaD
Antazoline—Dextropropoxyphene—OPRD1—coronary artery disease	0.00775	0.0648	CrCbGaD
Antazoline—Fentanyl—OPRD1—coronary artery disease	0.00767	0.0641	CrCbGaD
Antazoline—Phenoxybenzamine—SLC22A3—coronary artery disease	0.00659	0.0551	CrCbGaD
Antazoline—Methadone—OPRD1—coronary artery disease	0.00526	0.0439	CrCbGaD
Antazoline—Oxaprozin—PTGS2—coronary artery disease	0.00377	0.0315	CrCbGaD
Antazoline—Modafinil—CYP2C19—coronary artery disease	0.00313	0.0262	CrCbGaD
Antazoline—Phenoxybenzamine—ADRB2—coronary artery disease	0.00302	0.0252	CrCbGaD
Antazoline—Phenytoin—CYP2C19—coronary artery disease	0.00278	0.0232	CrCbGaD
Antazoline—Diphenhydramine—CYP2C19—coronary artery disease	0.00218	0.0182	CrCbGaD
Antazoline—Methadone—CYP2C19—coronary artery disease	0.0021	0.0176	CrCbGaD
Antazoline—Phenytoin—ALB—coronary artery disease	0.00154	0.0129	CrCbGaD
Antazoline—HRH1—Signaling by GPCR—PPBP—coronary artery disease	0.00123	0.0014	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—KNG1—coronary artery disease	0.00121	0.00137	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—AGTR1—coronary artery disease	0.0012	0.00137	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—AVPR1A—coronary artery disease	0.00119	0.00136	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADM2—coronary artery disease	0.00119	0.00135	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CXCL10—coronary artery disease	0.00117	0.00133	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCL4—coronary artery disease	0.00117	0.00133	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—OPRD1—coronary artery disease	0.00117	0.00133	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—coronary artery disease	0.00117	0.00133	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—coronary artery disease	0.00117	0.00133	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—UTS2—coronary artery disease	0.00115	0.00131	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—ADRB2—coronary artery disease	0.00114	0.00129	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TMED2—coronary artery disease	0.00113	0.00128	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—P2RY12—coronary artery disease	0.00112	0.00127	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PLCB3—coronary artery disease	0.00112	0.00127	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—coronary artery disease	0.00111	0.00126	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CASR—coronary artery disease	0.0011	0.00125	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—AVPR1A—coronary artery disease	0.00108	0.00123	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—BDKRB1—coronary artery disease	0.00108	0.00123	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—GNA12—coronary artery disease	0.00108	0.00123	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—RLN3—coronary artery disease	0.00108	0.00122	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—LRP8—coronary artery disease	0.00108	0.00122	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—DGKZ—coronary artery disease	0.00108	0.00122	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—coronary artery disease	0.00107	0.00122	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—ADM—coronary artery disease	0.00105	0.0012	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—UTS2—coronary artery disease	0.00105	0.00119	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—EDN2—coronary artery disease	0.00103	0.00117	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AES—coronary artery disease	0.00103	0.00117	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PDE4B—coronary artery disease	0.00103	0.00117	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—F2—coronary artery disease	0.00103	0.00117	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—EDN1—coronary artery disease	0.00102	0.00116	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PLCB3—coronary artery disease	0.00101	0.00115	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—P2RY12—coronary artery disease	0.00101	0.00115	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CCL5—coronary artery disease	0.00101	0.00115	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CX3CR1—coronary artery disease	0.001	0.00114	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CASR—coronary artery disease	0.001	0.00114	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HRH2—coronary artery disease	0.000993	0.00113	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—BDKRB1—coronary artery disease	0.000984	0.00112	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CX3CL1—coronary artery disease	0.000984	0.00112	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GNA12—coronary artery disease	0.000984	0.00112	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PPP3R1—coronary artery disease	0.000966	0.0011	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—ADM—coronary artery disease	0.000957	0.00109	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CCR3—coronary artery disease	0.000939	0.00107	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—coronary artery disease	0.000935	0.00106	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PDE4B—coronary artery disease	0.000933	0.00106	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—coronary artery disease	0.000915	0.00104	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—RHOC—coronary artery disease	0.000902	0.00102	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ACVR1B—coronary artery disease	0.000902	0.00102	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—HTR2A—coronary artery disease	0.000891	0.00101	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—C3—coronary artery disease	0.00089	0.00101	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CXCL2—coronary artery disease	0.000883	0.001	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NEDD4—coronary artery disease	0.000877	0.000997	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—F2R—coronary artery disease	0.000873	0.000992	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PF4—coronary artery disease	0.000855	0.000971	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MDK—coronary artery disease	0.000855	0.000971	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PDE3A—coronary artery disease	0.000855	0.000971	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—RAMP2—coronary artery disease	0.000855	0.000971	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCR3—coronary artery disease	0.000853	0.000969	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—EDNRB—coronary artery disease	0.000846	0.000961	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—AGT—coronary artery disease	0.000846	0.000961	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—RALBP1—coronary artery disease	0.000816	0.000926	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NPY5R—coronary artery disease	0.000816	0.000926	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—F2RL1—coronary artery disease	0.000816	0.000926	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCL3—coronary artery disease	0.000802	0.000911	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CXCL2—coronary artery disease	0.000802	0.000911	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—EDNRA—coronary artery disease	0.000799	0.000907	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—ADRB1—coronary artery disease	0.000795	0.000903	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—F2R—coronary artery disease	0.000793	0.000901	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—FZD2—coronary artery disease	0.000782	0.000888	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—UTS2R—coronary artery disease	0.000782	0.000888	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—F2—coronary artery disease	0.000781	0.000888	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—EDNRB—coronary artery disease	0.000768	0.000872	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SFRP2—coronary artery disease	0.000767	0.000871	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADORA1—coronary artery disease	0.000753	0.000855	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—APOA4—coronary artery disease	0.000753	0.000855	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADORA3—coronary artery disease	0.000753	0.000855	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—BDKRB2—coronary artery disease	0.000751	0.000853	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CXCL12—coronary artery disease	0.000751	0.000853	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PLCB1—coronary artery disease	0.000734	0.000834	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PGF—coronary artery disease	0.000727	0.000826	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PPBP—coronary artery disease	0.000727	0.000826	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—EDNRA—coronary artery disease	0.000725	0.000824	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—coronary artery disease	0.000723	0.000821	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—ADRB1—coronary artery disease	0.000722	0.00082	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—HTR7—coronary artery disease	0.000719	0.000817	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ITGA2B—coronary artery disease	0.000715	0.000812	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—DVL1—coronary artery disease	0.000715	0.000812	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—coronary artery disease	0.000714	0.000811	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—POMC—coronary artery disease	0.000712	0.000808	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CCL2—coronary artery disease	0.000696	0.000791	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GHR—coronary artery disease	0.000693	0.000788	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—OPRD1—coronary artery disease	0.000693	0.000788	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCL4—coronary artery disease	0.000693	0.000788	CbGpPWpGaD
Antazoline—HRH1—G alpha (q) signalling events—PIK3CA—coronary artery disease	0.000693	0.000787	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—KNG1—coronary artery disease	0.000683	0.000776	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—BDKRB2—coronary artery disease	0.000682	0.000775	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CXCL12—coronary artery disease	0.000682	0.000775	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—AGTR1—coronary artery disease	0.000679	0.000771	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PLCB1—coronary artery disease	0.000667	0.000758	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MEF2A—coronary artery disease	0.000665	0.000755	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TLE4—coronary artery disease	0.000665	0.000755	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CXCL10—coronary artery disease	0.000664	0.000754	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HTR7—coronary artery disease	0.000653	0.000742	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—APOA2—coronary artery disease	0.000648	0.000736	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—ADRB2—coronary artery disease	0.000644	0.000732	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AVPR1A—coronary artery disease	0.00064	0.000727	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PRKCE—coronary artery disease	0.000636	0.000723	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—KNG1—coronary artery disease	0.00062	0.000705	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—coronary artery disease	0.000619	0.000704	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—UTS2—coronary artery disease	0.000618	0.000702	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—AGTR1—coronary artery disease	0.000617	0.000701	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NR4A1—coronary artery disease	0.000605	0.000687	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CXCL10—coronary artery disease	0.000603	0.000685	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PLCB3—coronary artery disease	0.000599	0.00068	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—P2RY12—coronary artery disease	0.000599	0.00068	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HDAC9—coronary artery disease	0.000599	0.00068	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CX3CR1—coronary artery disease	0.000593	0.000673	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CASR—coronary artery disease	0.000593	0.000673	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—ADRB2—coronary artery disease	0.000585	0.000665	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GNA12—coronary artery disease	0.000581	0.00066	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—BDKRB1—coronary artery disease	0.000581	0.00066	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—P4HB—coronary artery disease	0.000581	0.00066	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CX3CL1—coronary artery disease	0.000581	0.00066	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PRKCE—coronary artery disease	0.000578	0.000656	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—EDN1—coronary artery disease	0.000576	0.000654	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CCL5—coronary artery disease	0.000571	0.000649	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PPP3R1—coronary artery disease	0.00057	0.000648	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADM—coronary artery disease	0.000565	0.000642	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CSF2—coronary artery disease	0.000563	0.000639	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PDE4B—coronary artery disease	0.000551	0.000626	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CYBB—coronary artery disease	0.000551	0.000626	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CXCL8—coronary artery disease	0.000551	0.000625	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—MMP3—coronary artery disease	0.00055	0.000624	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—coronary artery disease	0.000548	0.000623	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—EDN1—coronary artery disease	0.000523	0.000594	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCL5—coronary artery disease	0.000519	0.000589	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PRKCD—coronary artery disease	0.000515	0.000585	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CSF2—coronary artery disease	0.000511	0.00058	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCR3—coronary artery disease	0.000504	0.000572	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—HTR2A—coronary artery disease	0.000504	0.000572	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—C3—coronary artery disease	0.000503	0.000571	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CRK—coronary artery disease	0.000497	0.000565	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SH2B3—coronary artery disease	0.000491	0.000558	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—VWF—coronary artery disease	0.000491	0.000558	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ATP2A2—coronary artery disease	0.000491	0.000558	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—APOC3—coronary artery disease	0.000488	0.000554	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—LDLR—coronary artery disease	0.000485	0.000551	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—AGT—coronary artery disease	0.000478	0.000543	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PPP2CA—coronary artery disease	0.000476	0.000541	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCL3—coronary artery disease	0.000474	0.000538	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CXCL2—coronary artery disease	0.000474	0.000538	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SDC1—coronary artery disease	0.000468	0.000532	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—F2R—coronary artery disease	0.000468	0.000532	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PRKCD—coronary artery disease	0.000467	0.000531	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—FGB—coronary artery disease	0.000458	0.000521	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HTR2A—coronary artery disease	0.000457	0.00052	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—C3—coronary artery disease	0.000457	0.000519	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—EDNRB—coronary artery disease	0.000454	0.000515	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—THBS1—coronary artery disease	0.000447	0.000508	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PSMB5—coronary artery disease	0.000443	0.000503	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PSMA6—coronary artery disease	0.000443	0.000503	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—F2—coronary artery disease	0.000442	0.000502	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—AGT—coronary artery disease	0.000434	0.000493	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—EDNRA—coronary artery disease	0.000428	0.000487	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CYBA—coronary artery disease	0.000427	0.000485	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADRB1—coronary artery disease	0.000427	0.000485	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—DUSP6—coronary artery disease	0.000425	0.000482	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PLAT—coronary artery disease	0.000418	0.000474	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—BDKRB2—coronary artery disease	0.000403	0.000458	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CXCL12—coronary artery disease	0.000403	0.000458	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—POMC—coronary artery disease	0.000402	0.000457	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—F2—coronary artery disease	0.000401	0.000455	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—IL6ST—coronary artery disease	0.000399	0.000454	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—JUNB—coronary artery disease	0.000395	0.000449	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PLCB1—coronary artery disease	0.000394	0.000448	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HTR7—coronary artery disease	0.000386	0.000438	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ITGAV—coronary artery disease	0.000368	0.000418	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—KNG1—coronary artery disease	0.000366	0.000416	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—POMC—coronary artery disease	0.000365	0.000415	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CREB1—coronary artery disease	0.000365	0.000415	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AGTR1—coronary artery disease	0.000364	0.000414	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCL2—coronary artery disease	0.000357	0.000406	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—IL6R—coronary artery disease	0.000356	0.000405	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CXCL10—coronary artery disease	0.000356	0.000404	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PLG—coronary artery disease	0.000355	0.000403	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADRB2—coronary artery disease	0.000346	0.000393	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PRKCE—coronary artery disease	0.000341	0.000388	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—JAK2—coronary artery disease	0.000341	0.000387	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SOCS1—coronary artery disease	0.00034	0.000387	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—S100B—coronary artery disease	0.00034	0.000386	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SOCS3—coronary artery disease	0.000336	0.000382	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TGFBR2—coronary artery disease	0.000332	0.000377	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—KITLG—coronary artery disease	0.000332	0.000377	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—STAT5A—coronary artery disease	0.000325	0.000369	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MMP3—coronary artery disease	0.000325	0.000369	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—APOB—coronary artery disease	0.000314	0.000356	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CXCL8—coronary artery disease	0.000311	0.000353	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—JAK2—coronary artery disease	0.00031	0.000352	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—EDN1—coronary artery disease	0.000309	0.000351	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCL5—coronary artery disease	0.000306	0.000348	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CSF2—coronary artery disease	0.000302	0.000343	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—FGF1—coronary artery disease	0.000302	0.000343	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—LPL—coronary artery disease	0.0003	0.00034	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MEF2C—coronary artery disease	0.000297	0.000337	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—RPS6KB1—coronary artery disease	0.000297	0.000337	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ITGB3—coronary artery disease	0.000289	0.000329	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CXCL8—coronary artery disease	0.000283	0.000321	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PPP2CA—coronary artery disease	0.000281	0.000319	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PRKCD—coronary artery disease	0.000276	0.000314	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HTR2A—coronary artery disease	0.00027	0.000307	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—C3—coronary artery disease	0.00027	0.000306	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HIF1A—coronary artery disease	0.000257	0.000292	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AGT—coronary artery disease	0.000256	0.000291	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—LEP—coronary artery disease	0.000251	0.000285	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—APOE—coronary artery disease	0.000251	0.000285	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—APOA1—coronary artery disease	0.000248	0.000282	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—KDR—coronary artery disease	0.000246	0.00028	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MAPK14—coronary artery disease	0.000244	0.000278	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ESR1—coronary artery disease	0.00024	0.000272	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—F2—coronary artery disease	0.000237	0.000269	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—FN1—coronary artery disease	0.000237	0.000269	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IL6ST—coronary artery disease	0.000236	0.000268	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NFKBIA—coronary artery disease	0.000234	0.000266	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—KIT—coronary artery disease	0.000227	0.000257	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GSK3B—coronary artery disease	0.000218	0.000247	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—POMC—coronary artery disease	0.000216	0.000245	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CREB1—coronary artery disease	0.000216	0.000245	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCL2—coronary artery disease	0.000211	0.00024	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IL6R—coronary artery disease	0.00021	0.000239	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IGF1—coronary artery disease	0.000208	0.000236	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—MAPK1—coronary artery disease	0.000207	0.000235	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PIK3CA—coronary artery disease	0.000197	0.000224	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SERPINE1—coronary artery disease	0.000197	0.000224	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—FGF2—coronary artery disease	0.000191	0.000217	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NOS3—coronary artery disease	0.000188	0.000214	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—JAK2—coronary artery disease	0.000183	0.000208	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	0.000179	0.000204	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CXCL8—coronary artery disease	0.000167	0.00019	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	0.000161	0.000183	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CASP3—coronary artery disease	0.00016	0.000181	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—IL6—coronary artery disease	0.000159	0.00018	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCND1—coronary artery disease	0.000156	0.000177	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MMP9—coronary artery disease	0.000151	0.000171	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—AKT1—coronary artery disease	0.000146	0.000166	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—VEGFA—coronary artery disease	0.000136	0.000154	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TGFB1—coronary artery disease	0.000124	0.000141	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MAPK1—coronary artery disease	0.000122	0.000139	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	0.000106	0.00012	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IL6—coronary artery disease	9.38e-05	0.000107	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AKT1—coronary artery disease	8.65e-05	9.83e-05	CbGpPWpGaD
